GLP1R and Parkinson disease: We also demonstrated that EcN‐GLP‐1 showed significant neuroprotective impacts on MPTP‐induced PD mice via producing GLP‐1 therapeutic molecule and modulating the disturbed intestinal dysfunctions compared to that of EcN alone.